Home About Cytheris Corporate Overview Executive Management Board of Directors Clinical Advisory Board Academic Partners History Science Portfolio Overview Interleukin-7 NKT Ligands Pipeline & Products Development Pipeline IL-7 in Oncology IL-7 in HIV IL-7 in HCV NKT Ligands Intellectual Property Manufacturing Clinical Trials Clinical Trials Overview IL-7 Oncology Trials IL-7 HIV Trials IL-7 HCV Trials Other IL-7 Trials Business Development News Room Press Releases Calendar of Events Investors Careers Contact Us

Press Releases 2005
September 19, 2005
	Cytheris Launches a New Phase I Clinical Trial in the US for Its Recombinant Interleukin-7
	FR
July 11, 2005
	Cytheris Launches Two New Phase I Clinical Trials for Its Recombinant Interleukin-7
May 23, 2005
	Cytheris to Start Two Phase I/IIa Clinical Trials of CYT107, Its New Recombinant Interleukin-7, in Hepatitis C and Oncology
	FR